The latest biotech news

News and Trends 1 Sep 2020

Microbiome Therapies Threatened by Covid-19 Restrictions

Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of stool samples. Though these measures are now loosening in France, key safety challenges remain for companies using fecal microbiota. Fecal microbiota transplants — procedures where healthy individuals donate their gut microbes to a patient — have changed how we treat […]

September 1, 2020 - 5 minutesmins - By Jonathan Smith

unity biotechnology anti aging geroscience senolytics

News and Trends 25 Aug 2020

What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?

A drug developed by the US firm Unity Biotechnology — designed to slow the aging process — recently proved a dud in phase II for the treatment of osteoarthritis. How is this high-profile setback affecting European biotechs developing anti-aging treatments? Aging is a complex, multi-faceted process that makes people vulnerable to a wide range of […]

August 25, 2020 - 6 minutesmins - By Jonathan Smith

News and Trends 20 Aug 2020

Is Hepatitis D Healthcare Being Overlooked?

Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains an obstacle to tackling this aggressive infection. Earlier this month, the peptide drug Hepcludex became the first drug greenlit for hepatitis D treatment in Europe. This was a conditional market authorization granted to the German company MYR Pharmaceuticals based on […]

August 20, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 18 Aug 2020

Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s health – a historically neglected field in the biotech and pharma industry. Through this deal, Bayer has snapped up KaNDy Therapeutics’ first-in-class drug for treating hot flashes and night sweats, which often occur during the menopause. In a phase IIb […]

August 18, 2020 - 3 minutesmins - By Jonathan Smith

cancer vaccine virus ervaxx cell therapy

News and Trends 17 Aug 2020

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced a Nasdaq IPO at €180M ($213M). The excitement around messenger RNA (mRNA) vaccines against Covid-19 could also benefit other players in mRNA therapeutics. CureVac’s IPO was priced at €14 ($16) per share, giving the German company a valuation of around […]

August 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Aug 2020

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B ($2.6B) in the first half of 2020. While this is encouraging in the face of Covid-19, it hasn’t been smooth sailing for all startups in the field, with many struggling to stay afloat during crippling national lockdowns. The funding received […]

August 14, 2020 - 5 minutesmins - By Victor Kotsev

News and Trends 13 Aug 2020

Why are Some European Biotechs Going Public Without an IPO?

European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all are going the traditional Initial Public Offering (IPO) route. What does this mean for the dominance of the biotech IPO in Europe? In spite of the Covid-19 pandemic, biotech IPOs have continued unabated. In fact, a report from Bioworld found […]

August 13, 2020 - 7 minutesmins - By Jonathan Smith

News and Trends 11 Aug 2020

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

With the help of a huge €66M Series A round last week, the German startup T-knife is developing cancer T-cell immunotherapies with the help of genetically modified mice. However, this is just one of several cancer T-cell therapy startups making advances this year, with other innovations including off-the-shelf treatments and a potential universal cancer therapy. […]

August 11, 2020 - 8 minutesmins - By Kostas Vavitsas

News and Trends 6 Aug 2020

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

The leading UK institution University College London and the firm AlbionVC have made the first closing of a €112M (£100M) fund with the aim of investing in UCL research and spinouts with a focus on gene and cell therapy. This is the second so-called UCL Technology Fund and could double the size of the first, […]

August 6, 2020 - 2 minutesmins - By Antara Mazumdar

News and Trends 6 Aug 2020

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

A request for market approval of a skin patch developed by French biotech DBV Technologies to treat peanut allergy has been turned down by the FDA, which has requested more data and design changes. The response from the FDA is a blow for the company which had been working towards getting the patch onto the […]

August 6, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Aug 2020

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

UK biotech Oxford Nanopore has launched a portable test that can detect both Covid-19 and seasonal flu viruses in saliva or swabs in a little over an hour. The quick output of Oxford Nanopore’s test, called LamPORE, is expected to be a huge improvement on existing polymerase chain reaction (PCR) tests, considered the gold standard […]

August 5, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 30 Jul 2020

Llama-Derived Nanobodies Join the Fight Against Covid-19

Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas of the Covid-19 virus and other coronaviruses after raking in €23M in Series A. Based in Ghent, Belgium, ExeVir Bio is a spin-out of the research institute VIB established with the help of life sciences investor Fund+. Other investors include […]

July 30, 2020 - 3 minutesmins - By Victor Kotsev

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Microbiome Therapies Threatened by Covid-19 Restrictions

What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?

Is Hepatitis D Healthcare Being Overlooked?

Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

Why are Some European Biotechs Going Public Without an IPO?

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

Llama-Derived Nanobodies Join the Fight Against Covid-19

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!